Alexandre Perera Lluna
Jefe de Grupo Senior
Research group
Last Publications
- Barranco-Altirriba M, Granado, Minerva, Yanes, Oscar, Capellades, Jordi, Junza, Alexandra, Franch, Josep, Vendrell, Joan, Llauradó, Gemma, Valdés, Sergio, García, Eva, Bermúdez, Marcelino, Valdivieso, José Manuel, López, Víctor Miguel, Herrero, Celia, Falguera, Mireia, Vilanova, María Belén, Arteaga, Ingrid, Torán, Pere, Perera A, Castelblanco, Esmeralda and Mauricio, Dídac Guanine and pregnenolone sulfate are associated with incident type 2 diabetes in two independent populations Frontiers in Endocrinology . 16: 1706886.
- Rodriguez H, Nou-Fontanet L, Ormazabal-Herrero A, Casado-Rio M, Arias AY, Pias-Peleteiro LD, Gutierrez A, Perera A, Garcia-Cazorla A, Fons-Estupina C and Artuch-Iriberri R Cerebrospinal amino acid profiling in a large cohort of neuropediatric patients with epilepsy NEUROBIOLOGY OF DISEASE . 216: 107098-107098.
- Millat-Martínez P, Mora A, Condeminas PE, Castelló M, Alsina C, Fiestas B, Bason M, Esquerda-Areste M, Perera A, Nafria-Escalera B and Bassat Q Exploring reported causes of vaccine hesitancy among European adolescents and parents: results of a citizen science project BMC PUBLIC HEALTH . 25(1): 1136-1136.
Projects
- Project name:
- Design, Implementation and Development of a Psychosocial Study on COVID-19 Vaccine Trial Participation (RBDCOV Project)
- Leader
- Begoña Nafria Escalera
- Funding entities:
- European AIDS Treatment Group
- Code
- PFE00112
- Starting - finishing date:
- 2023 - 2024
News
-
Retaining talent and fostering public-private partnerships, some of the challenges that is facing the HealthTech sector
Xartec Salut has opened the debate on the main challenges of the Catalan ecosystem to become an international reference in the field of health technologies.
